BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32703544)

  • 21. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI.
    Yabuuchi H; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Hino T; Murayama Y; Yasumatsu R; Yamamoto H
    Eur Radiol; 2020 Dec; 30(12):6402-6412. PubMed ID: 32613285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of DTI and ARFI imaging in differential diagnosis of parotid tumours.
    Yu J; Du Y; Lu Y; Zhang W; Zhang D; Wang G; Li C
    Dentomaxillofac Radiol; 2016; 45(6):20160100. PubMed ID: 27351345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
    Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
    Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.
    Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F
    J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sonoelastography of parotid gland tumours: initial experience and identification of characteristic patterns.
    Klintworth N; Mantsopoulos K; Zenk J; Psychogios G; Iro H; Bozzato A
    Eur Radiol; 2012 May; 22(5):947-56. PubMed ID: 22270139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
    Mikaszewski B; Markiet K; SmugaƂa A; Stodulski D; Szurowska E; Stankiewicz C
    Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology].
    Masmoudi M; Hasnaoui M; Guizani R; Lahmar R; Jerbi S; Mighri K
    Pan Afr Med J; 2021; 39():10. PubMed ID: 34178238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
    Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
    Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.
    Christe A; Waldherr C; Hallett R; Zbaeren P; Thoeny H
    AJNR Am J Neuroradiol; 2011 Aug; 32(7):1202-7. PubMed ID: 21724574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paediatric parotid neoplasms: a 10 year retrospective imaging and pathology review of these rare tumours.
    Mamlouk MD; Rosbe KW; Glastonbury CM
    Clin Radiol; 2015 Mar; 70(3):270-7. PubMed ID: 25515793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of dynamic MRI studies in parotid tumors.
    Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
    Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CT features of parotid tumors: an analysis of 133 cases].
    Lu YC; Fan WJ; Shen JX; Xiao P
    Ai Zheng; 2007 Nov; 26(11):1263-7. PubMed ID: 17991330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing benign from malignant parotid gland tumours: low-dose multi-phasic CT protocol with 5-minute delay.
    Jin GQ; Su DK; Xie D; Zhao W; Liu LD; Zhu XN
    Eur Radiol; 2011 Aug; 21(8):1692-8. PubMed ID: 21547526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
    Fruehwald-Pallamar J; Czerny C; Holzer-Fruehwald L; Nemec SF; Mueller-Mang C; Weber M; Mayerhoefer ME
    NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of CT perfusion imaging for parotid neoplasms.
    Dong Y; Lei GW; Wang SW; Zheng SW; Ge Y; Wei FC
    Dentomaxillofac Radiol; 2014; 43(1):20130237. PubMed ID: 24186883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential diagnosis of parotid gland tumors using apparent diffusion coefficient, texture features, and their combination.
    Muraoka H; Kaneda T; Kondo T; Okada S; Tokunaga S
    Dentomaxillofac Radiol; 2023 Apr; 52(4):20220404. PubMed ID: 37015250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumors of the parotid gland: MR imaging characteristics of various histologic types.
    Joe VQ; Westesson PL
    AJR Am J Roentgenol; 1994 Aug; 163(2):433-8. PubMed ID: 8037045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Resolution MRI Microscopy Coil Assessment of Parotid Masses.
    Ginat DT; Christoforidis G
    Ear Nose Throat J; 2019; 98(9):562-565. PubMed ID: 30961381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gray scale and Doppler ultrasonography of the benign tumors of parotid gland (pleomorphic adenoma and Warthin's tumor). Pictorial essay.
    Fodor D; Pop S; Maniu A; Cosgaria M
    Med Ultrason; 2010 Sep; 12(3):238-44. PubMed ID: 21203603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parotid tumors: differentiation of benign and malignant tumors with quantitative sonographic analyses.
    Yonetsu K; Ohki M; Kumazawa S; Eida S; Sumi M; Nakamura T
    Ultrasound Med Biol; 2004 May; 30(5):567-74. PubMed ID: 15183220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.